BIOMAT Database Logo BIOMAT Database Logo

[Determining cyclic nucleotides in the plasma in a complicated course in the third trimester]. 1987

I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
[A simplified method of determining cyclic nucleotides].
January 1983, Laboratornoe delo,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
[Factors affecting the results of determining cyclic nucleotides in the blood plasma by a radioimmunological method].
January 1986, Laboratornoe delo,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
[Gonadotropin and plasma cyclic nucleotides].
November 1982, Nihon Sanka Fujinka Gakkai zasshi,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
Sources of cyclic nucleotides in plasma.
January 1974, The Journal of clinical investigation,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
[Plasma cyclic nucleotides in burned patients].
June 1986, Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
[Rheumatoid arthritis: cyclic nucleotides in the blood plasma].
January 1991, Terapevticheskii arkhiv,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
Third-trimester intrauterine pregnancy complicated by metastatic choriocarcinoma.
July 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
Low plasma cyclic nucleotides in multiple sclerosis.
January 1988, European neurology,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
[Cyclic nucleotides in the blood plasma in arterial hypertension].
November 1978, Kardiologiia,
I P Ivanov, and N V Kuz'mina, and N T Vorob'eva, and I V Proshina, and L I Vinnitskiĭ
Delivery course of macerated stillborn fetuses in the third trimester.
January 2008, Fetal diagnosis and therapy,
Copied contents to your clipboard!